Krispy Kreme raises $500 million after pricing U.S. IPO below range
The company priced 29.4 million shares at $17 each, below the $21 to $24 per share range it had set earlier. The IPO valued it…
featured
Young investors are abandoning stocks for crypto — and making millions
Is cryptocurrency financial kryptonite? The younger generations don’t think so.
DIVB: The Fund For Buyback Exposure
iShares U.S. Dividend And Buyback ETF’s (DIVB) investment mandate is to track the Morningstar US Dividend and Buyback index….
Passage Bio initiated overweight at Raymond James; expects a de-risking event this year
Passage Bio (PASG) is trading~3.4% higherin the post-market after Raymond James started the coverage of the stock with an overweight…
10 Best ESG Stocks to Buy Now
In this article, we discuss the 10 best ESG stocks to buy now. If you want to skip our detailed analysis of these companies,…
IPO Of Chinese Ride-Hailing Firm DiDi Makes Its President A Billionaire
Shares of the firm, which listed on the New York Stock Exchange on Wednesday, drifted down throughout the afternoon but still…
NASCAR: Chip Ganassi Racing team sold to Pitbull’s Trackhouse Racing
Chip Ganassi is selling his NASCAR operation to Trackhouse Racing after getting an offer “that required my attention,” he said….
Why Intellia Therapeutics Was a Winner on Wednesday
The company is about to fatten its coffers significantly.
Synchronoss Announces Closing of $235 Million of Common Stock and Senior Notes Offerings
In addition, Synchronoss raised $75 million through aprivate placement of preferred stock Net proceeds used to refinance the…
Vor Biopharma: Targeted Therapies For Transplants
Vor has a lead asset entering phase 1 clinical trials for AML that has the potential to become the standard of care for stem…